James V. Caruso

2023

In 2023, James V. Caruso earned a total compensation of $2M as President and Chief Executive Officer at Cellectar Biosciences, a 34% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$450,000
Option Awards$715,140
Salary$600,000
Stock Awards$107,582
Other$92,418
Total$1,965,140

Caruso received $715.1K in option awards, accounting for 36% of the total pay in 2023.

Caruso also received $450K in non-equity incentive plan, $600K in salary, $107.6K in stock awards and $92.4K in other compensation.

Rankings

In 2023, James V. Caruso's compensation ranked 533rd out of 2,918 executives tracked by ExecPay. In other words, Caruso earned more than 81.7% of executives.

ClassificationRankingPercentile
All
533
out of 2,918
82nd
Division
Manufacturing
307
out of 1,608
81st
Major group
Chemicals And Allied Products
215
out of 901
76th
Industry group
Drugs
212
out of 864
76th
Industry
Pharmaceutical Preparations
132
out of 622
79th
Source: SEC filing on April 26, 2024.

Caruso's colleagues

We found two more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2023.

2023

Jarrod Longcor

Cellectar Biosciences

Chief Operating Officer

2023

Chad Kolean

Cellectar Biosciences

Chief Financial Officer

News

You may also like